Nivolumab in Recurrent and/or Metastatic SCCHN

Clinical trial NCT03226756 · COMPLETED

Trial details

NCT number: NCT03226756
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent and/or Metastatic Platinum-refractory SCCHN

Start date: 2017-07-07
Primary completion: 2017-12-31
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.